HEM Pharma Inc. (KOSDAQ:376270)
South Korea
· Delayed Price · Currency is KRW 59,500
-1,500 (-2.46%)
At close: Apr 28, 2026
HEM Pharma Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 |
|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
| Cash & Equivalents | 13,785 | 6,274 |
| Short-Term Investments | - | 5,000 |
| Cash & Short-Term Investments | 13,785 | 11,274 |
| Cash Growth | 22.27% | - |
| Accounts Receivable | 1,655 | 4,371 |
| Other Receivables | 46.01 | 65.79 |
| Receivables | 1,708 | 4,437 |
| Inventory | 1,505 | 975.27 |
| Prepaid Expenses | 1,207 | 521.28 |
| Other Current Assets | 4,430 | 98.49 |
| Total Current Assets | 22,635 | 17,306 |
| Property, Plant & Equipment | 26,116 | 17,628 |
| Long-Term Investments | 573.29 | 46.75 |
| Goodwill | 14.34 | - |
| Other Intangible Assets | 1,443 | 793.74 |
| Other Long-Term Assets | 1,052 | 1,087 |
| Total Assets | 51,834 | 36,862 |
| Accounts Payable | 1,536 | 1,125 |
| Accrued Expenses | 891.97 | 576.49 |
| Short-Term Debt | 13,448 | 6,000 |
| Current Portion of Long-Term Debt | 166.56 | 166.56 |
| Current Portion of Leases | 444.19 | 316.2 |
| Current Income Taxes Payable | 3.59 | - |
| Other Current Liabilities | 23,996 | 892.18 |
| Total Current Liabilities | 40,486 | 9,077 |
| Long-Term Debt | 3,566 | 305.36 |
| Long-Term Leases | 1,630 | 1,033 |
| Pension & Post-Retirement Benefits | 614.23 | 68.25 |
| Long-Term Deferred Tax Liabilities | 68.04 | - |
| Other Long-Term Liabilities | 254.83 | 260.76 |
| Total Liabilities | 46,619 | 10,744 |
| Common Stock | 3,579 | 3,481 |
| Additional Paid-In Capital | 69,839 | 65,911 |
| Retained Earnings | -75,874 | -51,864 |
| Comprehensive Income & Other | 7,442 | 8,590 |
| Total Common Equity | 4,986 | 26,118 |
| Minority Interest | 228.45 | - |
| Shareholders' Equity | 5,215 | 26,118 |
| Total Liabilities & Equity | 51,834 | 36,862 |
| Total Debt | 19,255 | 7,821 |
| Net Cash (Debt) | -5,470 | 3,453 |
| Net Cash Per Share | -777.56 | 543.32 |
| Filing Date Shares Outstanding | 7.1 | 6.95 |
| Total Common Shares Outstanding | 7.1 | 6.95 |
| Working Capital | -17,851 | 8,229 |
| Book Value Per Share | 702.18 | 3756.88 |
| Tangible Book Value | 3,529 | 25,324 |
| Tangible Book Value Per Share | 496.92 | 3642.70 |
| Land | 7,213 | 6,936 |
| Buildings | 5,939 | 3,510 |
| Machinery | 10,137 | 8,636 |
| Construction In Progress | 2,615 | 1,852 |
Source: S&P Capital IQ. Standard template. Financial Sources.